Gain Therapeutics Outlines Key Objectives for

BETHESDA, Md., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company transforming...

Related Keywords

Australia ,Joleen Schultz ,Eric Richman ,European Union Horizon ,Silverstein Foundation For Parkinson ,Gain Therapeutics Inc ,Joleen Schultz Associates ,Human Research Ethics Committee ,Michaelj Fox Foundation For Parkinson Research ,Nasdaq ,Alphafold Protein Structure Database ,Gain Therapeutics ,Silverstein Foundation ,Nasdaq Ganx ,Nc ,